Search

Search Constraints

You searched for: Author/Creator Lobo, Ines

Search Results

1. Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials. Issue 10378 (4th March 2023)